## SYK: Stryker Corporation - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 -1.2% below STRENGTH zone (4.0-10.0%); PEG 1.86 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($352.10)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Northwestern Mutual Wealth Management Co. Has $21.53 Million Stake in Stryker Corporation $SYK**
- Source: MarketBeat | 20251202T111051 | Somewhat-Bullish | Relevance: 99%
- Northwestern Mutual Wealth Management Co. increased its stake in Stryker Corporation to 54,420 shares, valued at $21.53 million, during the second quarter. The article highlights significant insider selling activity, with Director Ronda E. Stryker selling 276,173 shares for about $97.6 million. Stryker exceeded quarterly earnings expectations and received a consensus "Moderate Buy" rating from analysts with an average price target of $434.37.

**2. Boston Family Office LLC Purchases 1,882 Shares of Stryker Corporation $SYK**
- Source: MarketBeat | 20251201T083128 | Somewhat-Bullish | Relevance: 99%
- Boston Family Office LLC increased its stake in Stryker Corporation by 2.9% in Q2, acquiring 1,882 shares, bringing its total to 66,391 shares valued at $26,266,000. Other major institutions like Vanguard, Price T. Rowe, Geode, and Norges Bank also increased their holdings, while corporate insiders sold a significant number of shares. Stryker recently exceeded quarterly EPS estimates with strong revenue growth and provided optimistic FY2025 EPS guidance, leading analysts to rate the stock as a "Moderate Buy."

**3. Schroder Investment Management Group Acquires 137,100 Shares of Stryker Corporation $SYK**
- Source: MarketBeat | 20251130T123831 | Somewhat-Bullish | Relevance: 99%
- Schroder Investment Management Group increased its stake in Stryker Corporation by 10.7% in Q2, acquiring an additional 137,100 shares to hold a total of 1,414,987 shares valued at $559.8 million. This acquisition comes amidst significant insider selling, with Director Ronda E. Stryker selling 276,173 shares for $97.6 million and other insiders selling 522,118 shares totaling $185.4 million over the last quarter. Despite the insider selling, Stryker reported strong quarterly results with EPS of $3.19 and revenue of $6.06 billion, and provided positive FY2025 guidance.

**4. Railway Pension Investments Ltd Cuts Position in Stryker Corporation $SYK**
- Source: MarketBeat | 20251201T133834 | Somewhat-Bullish | Relevance: 98%
- Railway Pension Investments Ltd reduced its stake in Stryker Corporation by 4.7% in Q2, selling 1,900 shares and ending with 38,600 shares valued at $15.27 million. Institutional ownership of Stryker stands at 77.09%, while insiders sold a total of 522,118 shares valued at approximately $185.38 million in the last quarter. Analysts maintain a "Moderate Buy" rating with an average price target of $434.37, following strong Q3 results and positive FY2025 guidance.

**5. Groupama Asset Managment Buys 3,748 Shares of Stryker Corporation $SYK**
- Source: MarketBeat | 20251130T113908 | Somewhat-Bullish | Relevance: 98%
- Groupama Asset Management significantly increased its stake in Stryker Corporation in Q2 2025, purchasing 3,748 additional shares, bringing their total holdings to 5,593 shares valued at approximately $2.20 million. Wall Street analysts maintain a "Moderate Buy" rating for Stryker with an average target price of $434.37. The article also details recent insider selling and other institutional investor activities in Stryker stock.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-14 | Truist Securiti | $400 | $392 | +2% |
| 2025-11-14 | Wells Fargo | $456 | $452 | +1% |
| 2025-11-14 | Needham | $448 | $448 | 0% |
| 2025-11-14 | BTIG | $410 | $410 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-14 | Truist Securiti | main | Hold |
| 2025-11-14 | Wells Fargo | main | Overweight |
| 2025-11-14 | Needham | reit | Buy |
| 2025-11-14 | BTIG | reit | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 6 ($34.68M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 8.8% (+0.8%)
- Blackrock Inc.: 7.0% (+0.4%)
- JPMORGAN CHASE & CO: 6.2% (+95.3%)
- Greenleaf Trust: 4.3% (-0.3%)
- State Street Corpora: 3.9% (-0.1%)

### Key Risks

1. Heavy insider selling: $35M sold (6 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.86 elevated, pricing in significant growth expectations. Forward P/E 24.5x stretched relative to 10% growth. Balance sheet: $1.4B free cash flow. Insider selling cluster ($34.7M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $135.3B |
| Beta | 0.90 |
| 52W Range | $329.16 - $406.19 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.86 |
| Forward P/E | 24.5 |
| Current P/E | 27.1 |
| YoY Growth | 10.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 3.6% to -1.2% (-4.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.2pp (needs >4.0% for momentum thesis). Below SMA200 (0.97x), long-term trend not supportive. MACD histogram positive (1.12), confirming momentum. RSI neutral at 49.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.18% (CS: 46) | Neutral |
| RSI_14 | 48.8 | Neutral |
| MACD Histogram | 1.12 | Bullish |
| vs SMA20 | 1.006x | Above |
| vs SMA50 | 0.994x | Below |
| vs SMA200 | 0.971x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $366.68
- **Stop Loss:** $352.10 (4.0% risk)
- **Target:** $381.26 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 68
- **Position Value:** $24,934.24
- **Portfolio %:** 24.93%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-01-27 (Est: $4.39)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.13 | $3.19 | +1.9% |
| 2025Q2 | $3.07 | $3.13 | +1.9% |
| 2025Q1 | $2.73 | $2.84 | +4.0% |
| 2024Q4 | $3.87 | $4.01 | +3.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*